Do natural killer cells accelerate or prevent autoimmunity in multiple sclerosis?

ISSN： 1460-2156

Source： Brain, Vol.131, Iss.7, 2008-07, pp. : 1681-1683

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The regulatory role of natural killer cells in multiple sclerosis

By Takahashi Kazuya Aranami Toshimasa Endoh Masumi Miyake Sachiko Yamamura Takashi

Brain, Vol. 127, Iss. 9, 2004-09 ,pp. : 1917-1927

Oxford University Press

Access to resources Recommend Favorite

Contrasting roles for Vα14+ natural killer T cells in a viral model for multiple sclerosis

By Tsunoda Ikuo Tanaka Tomoko Taniguchi Masaru Fujinami Robert

Journal of NeuroVirology, Vol. 15, Iss. 1, 2008-12 ,pp. : 90-98

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Multiple sclerosis: disease markers accelerate progress

By Fox R.J. Rudick R.A.

Lancet Neurology, Vol. 3, Iss. 1, 2004-01 ,pp. : 10-10

Elsevier

Access to resources Recommend Favorite

Interferon- increases BAFF levels in multiple sclerosis: implications for B cell autoimmunity

By Krumbholz M.

Brain, Vol. 131, Iss. 6, 2008-06 ,pp. : 1455-1463

Oxford University Press

Access to resources Recommend Favorite

Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese

By Matsuoka Takeshi

Brain, Vol. 130, Iss. 5, 2007-05 ,pp. : 1206-1223

Oxford University Press

Access to resources Recommend Favorite